These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2632243)

  • 21. Subchronic physostigmine pretreatment in marmosets: absence of side effects and effectiveness against soman poisoning with negligible postintoxication incapacitation.
    Philippens IH; Vanwersch RA; Groen B; Olivier B; Bruijnzeel PL; Melchers BP
    Toxicol Sci; 2000 Jan; 53(1):84-91. PubMed ID: 10653525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of next generation medical countermeasures to nerve agent poisoning.
    Wetherell J; Price M; Mumford H; Armstrong S; Scott L
    Toxicology; 2007 Apr; 233(1-3):120-7. PubMed ID: 16979808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term behavioral and learning abnormalities produced by the irreversible cholinesterase inhibitor soman: effect of a standard pretreatment regimen and clonidine.
    Buccafusco JJ; Heithold DL; Chon SH
    Toxicol Lett; 1990 Aug; 52(3):319-29. PubMed ID: 2389260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of anti-convulsant and life-preserving capacities of three types of auto-injector therapies against soman intoxication in rats.
    Myhrer T; Enger S; Aas P
    Drug Test Anal; 2013 Aug; 5(8):693-701. PubMed ID: 22977014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection by sustained release of physostigmine and procyclidine of soman poisoning in rats.
    Choi EK; Park D; Yon JM; Hur GH; Ha YC; Che JH; Kim J; Shin S; Jang JY; Hwang SY; Seong YH; Kim DJ; Kim JC; Kim YB
    Eur J Pharmacol; 2004 Nov; 505(1-3):83-91. PubMed ID: 15556140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection by a transdermal patch containing physostigmine and procyclidine of soman poisoning in dogs.
    Kim WS; Cho Y; Kim JC; Huang ZZ; Park SH; Choi EK; Shin S; Nam SY; Kang JK; Hwang SY; Kim YB
    Eur J Pharmacol; 2005 Nov; 525(1-3):135-42. PubMed ID: 16256978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physostigmine--an overview as pretreatment drug for organophosphate intoxication.
    Somani SM; Dube SN
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):367-87. PubMed ID: 2676871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of physostigmine on the startle in guinea pigs: two mechanisms involved.
    Philippens IH; Olivier B; Melchers BP
    Pharmacol Biochem Behav; 1997 Dec; 58(4):909-13. PubMed ID: 9408195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of physostigmine as a pretreatment for organophosphate poisoning.
    Miller SA; Blick DW; Kerenyi SZ; Murphy MR
    Pharmacol Biochem Behav; 1993 Feb; 44(2):343-7. PubMed ID: 8446666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-enzymatic pretreatment of nerve agent (soman) poisoning: a brief state-of-the-art review.
    van Helden HP; Joosen MJ; Philippens IH
    Toxicol Lett; 2011 Sep; 206(1):35-40. PubMed ID: 21554933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of two scopolamine and physostigmine pretreatment regimens against nerve agent poisoning in the dog.
    Bonhage MR; Chilcoat CD; Li Q; Melendez V; Flournoy WS
    J Vet Pharmacol Ther; 2009 Apr; 32(2):146-53. PubMed ID: 19290944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection against soman-induced seizures in rats: relationship among doses of prophylactics, soman, and adjuncts.
    Myhrer T; Nguyen NH; Andersen JM; Aas P
    Toxicol Appl Pharmacol; 2004 May; 196(3):327-36. PubMed ID: 15094303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy comparison of scopolamine (SCP) and diazepam (DZ) against soman-induced lethality in guinea pigs.
    Harris LW; Gennings C; Carter WH; Anderson DR; Lennox WJ; Bowersox SL; Solana RP
    Drug Chem Toxicol; 1994; 17(1):35-50. PubMed ID: 8168432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of motor performance decrement following soman poisoning in mice.
    Koplovitz I; Romano JA; Stewart JR
    Drug Chem Toxicol; 1989; 12(3-4):221-35. PubMed ID: 2632244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Side effects of physostigmine as a pretreatment in guinea pigs.
    Philippens IH; Wolthuis OL; Busker RW; Langenberg JP; Melchers BP
    Pharmacol Biochem Behav; 1996 Sep; 55(1):99-105. PubMed ID: 8870044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection against both lethal and behavioral effects of soman.
    Harris LW; McDonough JH; Stitcher DL; Lennox WJ
    Drug Chem Toxicol; 1984; 7(6):605-24. PubMed ID: 6534735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minimum effective drug concentrations of a transdermal patch system containing procyclidine and physostigmine for prophylaxis against soman poisoning in rhesus monkeys.
    Cho Y; Kim WS; Hur GH; Ha YC
    Environ Toxicol Pharmacol; 2012 Jan; 33(1):1-8. PubMed ID: 22051905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
    Maxwell DM; Brecht KM; Lenz DE; O'Neill BL
    J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of acute physostigmine-hyoscine pretreatment on the neurochemical changes produced by soman in the guinea-pig.
    Fosbraey P; Wetherell JR; French MC
    Neurochem Int; 1991; 18(2):265-73. PubMed ID: 20504702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the neuroprotective efficacy of pharmacological pretreatment and antidotal treatment in soman-poisoned rats.
    Kassa J; Krejcová G; Samnaliev I
    Acta Medica (Hradec Kralove); 2003; 46(3):101-7. PubMed ID: 14677718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.